Trial intelligence / Profile preview

Dual TAP Block in Pediatric Renal Transplant

NCT02858622Completed

Sponsor
Cairo University
Start
Dec 2016
Primary completion
Jan 2019
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of bupivacaine hydrochloride 0.75% injection in postoperative pain (2 arms), sponsored by Cairo University. Primary endpoint: Total dose of rescue analgesia at 24 hours. Started Dec 2016; status: completed.

02

Drugs

bupivacaine hydrochloride 0.75% injection
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT02858622.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02858622.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call